Form 4 for XYL Xylem Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001562180-24-002289 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01 | XYL | Cerwinka Franz | SVP, Pres, AWS, Bus Trnsform | A - Grant | $127.94 | +4,722 | 14.2K | +50% | +$604.1K |
| DM | 2024-03-05 | 2024-03-01 | XYL | Cerwinka Franz | SVP, Pres, AWS, Bus Trnsform | F - Tax | $127.94 | -2,239 | 12.7K | -15% | -$286.5K |
| D | 2024-03-05 | 2024-03-01 | XYL | Cerwinka Franz | SVP, Pres, AWS, Bus Trnsform | S - Sale | $127.44 | -1,341 | 12.9K | -9% | -$170.9K |
| D | 2024-03-05 | 2024-03-01 | XYL | Cerwinka Franz | SVP, Pres, AWS, Bus Trnsform | A - Grant | $127.94 | +5,288 | 5,288 | New | +$676.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 1,203 | $127.94 | 12,953 | D | — | — | (F1) Reflects the acquisition of 1,203 shares of common stock upon vesting of performance-based restricted stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. |
| 2 | Common | Common Stock | 2024-03-01 | A | A | 1,956 | $127.94 | 14,909 | D | — | — | (F2) Reflects the acquisition of 1,956 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. |
| 3 | Common | Common Stock | 2024-03-01 | F | D | 1,509 | $127.94 | 13,400 | D | — | — | (F3) Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). |
| 4 | Common | Common Stock | 2024-03-01 | F | D | 730 | $127.94 | 12,670 | D | — | — | (F4) Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (193), March 1, 2022 (246), and March 1, 2023 (291) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). |
| 5 | Common | Common Stock | 2024-03-01 | A | A | 1,563 | $127.94 | 14,233 | D | — | — | (F5) Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. |
| 6 | Common | Common Stock | 2024-03-01 | S | D | 1,341 | $127.44 | 12,892 | D | — | — | (F6) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a price of $127.44. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 7 | Derivative | Stock Options (Right to buy) | 2024-03-01 | A | A | 5,288 | $127.94 | 5,288 | D | $127.94 · — to 2034-03-01 | 5,288 Common Stock | (F7) Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. |